Market Overview:
The global cyproheptadine market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The patent segment is expected to dominate the market in terms of revenue share during the forecast period. However, the generic segment is projected to grow at a higher CAGR as compared to the patent segment over the forecast period. The hospital application segment dominates in terms of revenue share and is anticipated to maintain its dominance throughout 2030 owing to increasing number of hospitals across developed and developing countries.
Product Definition:
Cyproheptadine is a medication used to treat various conditions such as allergies, insomnia, and serotonin syndrome. Cyproheptadine can also be used as an appetite stimulant in people with eating disorders.
Patent:
Patent is a property right granted by the government for an invention. The patent gives the right to manufacture and sell the product or process defined in the patent document. A Patent can be obtained through originality, innovation, useful properties or processes, and industrial application.
Patentability of a new drug is determined on the basis of medical utility and novel chemical entities (NCE) which are novelty-related characteristics that distinguish a new drug from an old one.
Generic:
Cyproheptadine, also known ascyclosporine napsylate is an immunosuppressive drug. It prevents the immune response to any more cell damage done by certain viruses and bacteria. This medication is used for treating a wide range of diseases such as lupus, rheumatoid arthritis, scleroderma and many others.
Application Insights:
The drugstore application segment led the global cyproheptadine market in 2017. This is attributed to increasing product usage for treating symptoms of hay fever and allergic rhinitis among others. The hospital application segment is expected to witness the fastest growth over the forecast period owing to rising prevalence of allergies and asthma, which calls for treatment with antihistamines like cyproheptadine.
On-line pharmacies are anticipated to be one of the prominent applications as they offer easy access and delivery at doorsteps without any extra effort on behalf of customer or pharmacist. Moreover, these online stores do not require any extra equipment other than a computerized system; this factor is anticipated to boost on-line pharmacy sales over the forecast period thereby driving demand for Cyproheptadinum Tokelauicum (DPT) drugs globally.
Regional Analysis:
North America dominated the global cyproheptadine market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness regarding sleep disorders, rising prevalence of obesity and diabetes, and growing preference for non-invasive procedures over surgery for treatment of these conditions. In addition, presence of key players such as Actavis (US), Inc.; Sandoz International GmbH; Mylan N.V.; Pfizer Inc.
Growth Factors:
- Increasing prevalence of anxiety disorders and other psychiatric disorders
- Rising awareness about the benefits of Cyproheptadine for the treatment of various psychiatric disorders
- Growing demand for off-label use of Cyproheptadine in the treatment of various medical conditions
- increasing number of clinical studies supporting the efficacy and safety profile of Cyproheptadine
- expanding distribution network for marketing and sales
Scope Of The Report
Report Attributes
Report Details
Report Title
Cyproheptadine Market Research Report
By Type
Patent, Generic
By Application
Hospital, Drug Store, On-line
By Companies
MSD, Aero-Chem, Allena Pharmaceuticals, Caillon and Hamonet, Teriak, Arena Pharmaceuticals, Pharma Arte, Fu Yuan Pharmaceutical, Panbiotic Laboratories, Royal Pharma, Novartis, General Pharma, Qualipharm, Faes Pharma, Apex Pharma, Cipla Medpro South Africa, Abbott, Kalbe, Laboratoires Servier, Medphano, Nichi-Iko Pharmaceutical, Teva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Cyproheptadine Market Report Segments:
The global Cyproheptadine market is segmented on the basis of:
Types
Patent, Generic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, On-line
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MSD
- Aero-Chem
- Allena Pharmaceuticals
- Caillon and Hamonet
- Teriak
- Arena Pharmaceuticals
- Pharma Arte
- Fu Yuan Pharmaceutical
- Panbiotic Laboratories
- Royal Pharma
- Novartis
- General Pharma
- Qualipharm
- Faes Pharma
- Apex Pharma
- Cipla Medpro South Africa
- Abbott
- Kalbe
- Laboratoires Servier
- Medphano
- Nichi-Iko Pharmaceutical
- Teva
Highlights of The Cyproheptadine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Patent
- Generic
- By Application:
- Hospital
- Drug Store
- On-line
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cyproheptadine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cyproheptadine is an antihistamine that blocks the effects of histamine. Histamine is a chemical that causes inflammation and itching. Cyproheptadine can be used to treat allergies, hay fever, and other conditions caused by histamines.
Some of the key players operating in the cyproheptadine market are MSD, Aero-Chem, Allena Pharmaceuticals, Caillon and Hamonet, Teriak, Arena Pharmaceuticals, Pharma Arte, Fu Yuan Pharmaceutical, Panbiotic Laboratories, Royal Pharma, Novartis, General Pharma, Qualipharm, Faes Pharma, Apex Pharma, Cipla Medpro South Africa, Abbott, Kalbe, Laboratoires Servier, Medphano, Nichi-Iko Pharmaceutical, Teva.
The cyproheptadine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cyproheptadine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cyproheptadine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cyproheptadine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cyproheptadine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cyproheptadine Market Size & Forecast, 2018-2028
4.5.1 Cyproheptadine Market Size and Y-o-Y Growth
4.5.2 Cyproheptadine Market Absolute $ Opportunity
Chapter 5 Global Cyproheptadine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cyproheptadine Market Size Forecast by Type
5.2.1 Patent
5.2.2 Generic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cyproheptadine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cyproheptadine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 On-line
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cyproheptadine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cyproheptadine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cyproheptadine Analysis and Forecast
9.1 Introduction
9.2 North America Cyproheptadine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cyproheptadine Market Size Forecast by Type
9.6.1 Patent
9.6.2 Generic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cyproheptadine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 On-line
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cyproheptadine Analysis and Forecast
10.1 Introduction
10.2 Europe Cyproheptadine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cyproheptadine Market Size Forecast by Type
10.6.1 Patent
10.6.2 Generic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cyproheptadine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 On-line
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cyproheptadine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cyproheptadine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cyproheptadine Market Size Forecast by Type
11.6.1 Patent
11.6.2 Generic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cyproheptadine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 On-line
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cyproheptadine Analysis and Forecast
12.1 Introduction
12.2 Latin America Cyproheptadine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cyproheptadine Market Size Forecast by Type
12.6.1 Patent
12.6.2 Generic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cyproheptadine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 On-line
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cyproheptadine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cyproheptadine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cyproheptadine Market Size Forecast by Type
13.6.1 Patent
13.6.2 Generic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cyproheptadine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 On-line
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cyproheptadine Market: Competitive Dashboard
14.2 Global Cyproheptadine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MSD
14.3.2 Aero-Chem
14.3.3 Allena Pharmaceuticals
14.3.4 Caillon and Hamonet
14.3.5 Teriak
14.3.6 Arena Pharmaceuticals
14.3.7 Pharma Arte
14.3.8 Fu Yuan Pharmaceutical
14.3.9 Panbiotic Laboratories
14.3.10 Royal Pharma
14.3.11 Novartis
14.3.12 General Pharma
14.3.13 Qualipharm
14.3.14 Faes Pharma
14.3.15 Apex Pharma
14.3.16 Cipla Medpro South Africa
14.3.17 Abbott
14.3.18 Kalbe
14.3.19 Laboratoires Servier
14.3.20 Medphano
14.3.21 Nichi-Iko Pharmaceutical
14.3.22 Teva
